You are here: Home » Markets » IPOS » News
Business Standard

Top headlines: Paytm IPO subscribed 1.89 times; Nykaa makes stellar debut

Business Standard brings you the top stories from today

Topics
top news of the day | Top Business Headlines | initial public offering (IPO)

BS Web Team 

Nykaa
Falguni Nayar (C-L), MD and CEO of Nykaa, along with her daughter Advaita (C-R), Bollywood actress Katrina Kaif and others attend the company's IPO listing ceremony at the NSE, in Mumbai (Photo: PTI)

Beauty startup surges to near $13-bn valuation in stock market debut

Shares of cosmetics-to-fashion platform made a blockbuster opening on Wednesday, valuing the Indian company at near $13 billion, in the latest startup listing after food delivery firm Zomato's stellar debut in July.

Shares of FSN E-Commerce Ventures, the profit-making company that owns the brand, soared 89.2% to Rs 2,129 after opening at Rs 2,018 in pre-open trade. Read more

Paytm's Rs 18,300-cr IPO gets subscribed 1.89 times on Day 3

Financial services firm Paytm’s initial public offering (IPO), worth Rs 18,300 crore, on Wednesday got fully subscribed on the third day of bidding.

As per data available on the BSE, IPO has been subscribed 1.89 times so far, with the qualified institutional buyers (QIBs) tranche being subscribed 2.79 times. Read more

Bank of Baroda Q2 net profit up 24% at Rs 2,088 cr, asset quality improves

Public sector lender Bank of Baroda on Wednesday reported 24% rise in standalone net profit at Rs 2,088 crore in the September quarter as against Rs 1,679 crore in year-ago period.

Net interest income rose 2% to Rs 7,566 crore as compared to Rs 7,508 crore in Q2FY21. Read more

Ideal time for Covid booster is 6 months after 2nd dose: MD

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Chairman and Managing Director Krishna Ella said on Wednesday, and also emphasised the importance of having a nasal vaccine.

He also pointed out that his company was the first in the world to develop a Zika vaccine. Read more

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 10 2021. 18:12 IST
RECOMMENDED FOR YOU
.